Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant OLIG2 antibody (AA 200-300)

This Rabbit Monoclonal antibody specifically detects OLIG2 in IHC (f). It exhibits reactivity toward Human.
Catalog No. ABIN7126163

Quick Overview for Recombinant OLIG2 antibody (AA 200-300) (ABIN7126163)

Target

See all OLIG2 Antibodies
OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

Antibody Type

Recombinant Antibody

Reactivity

  • 81
  • 44
  • 41
  • 6
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 72
  • 24
  • 1
Rabbit

Clonality

  • 64
  • 33
Monoclonal

Conjugate

  • 54
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This OLIG2 antibody is un-conjugated

Application

  • 53
  • 40
  • 35
  • 18
  • 15
  • 13
  • 13
  • 11
  • 11
  • 9
  • 8
  • 4
  • 3
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Binding Specificity

    • 16
    • 13
    • 9
    • 7
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 200-300

    Specificity

    Olig2, a basic helix loop helix transcription factor, is involved in oligo-dendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuroepithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid/rhabdoid tumor, and haemangioblastomas. Compared to the strong staining seen in glioma samples, a weak expression is observed in non-tumoral brain tissue.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment (around aa200-300) of human OLIG2 protein (exact sequence is proprietary)

    Isotype

    IgG
  • Application Notes

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: THP-1 cells. Human brain or astrocytoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

    Alternative Name

    OLIG2

    Background

    Basic helix loop helix protein class B1 (bHLHB1), basic helix-loop-helix protein 19 (bHLHe19), OLIG2, Oligodendrocyte lineage transcription factor 2, Oligodendrocyte specific bHLH transcription factor 2, Oligodendrocyte transcription factor 2, Protein kinase C-binding protein 2 (PRKCBP2), RACK17,OLIG2 (Marker of Glial Brain Tumors)
    Cellular localisation: Nucleus. Cytoplasm.

    Molecular Weight

    32kDa

    Gene ID

    10215, 176977

    UniProt

    Q13516
You are here:
Chat with us!